B7-H1 pathway and its role in the evasion of tumor immunity. (Q35117398)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12721664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

B7-H1 pathway and its role in the evasion of tumor immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12721664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12721664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Lieping Chen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12721664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

30 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12721664%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12721664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12721664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

281-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12721664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12721664%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00109-003-0430-2

3 November 2019

exact match

0 references

cites work

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Tuning tumor-specific T-cell activation: a matter of costimulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

A fresh look at tumor immunosurveillance and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

B7 family molecules: novel immunomodulators at the maternal-fetal interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Expression of programmed death 1 ligands by murine T cells and APC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Laser capture microdissection-based expression profiling identifies PD1-ligand as a target of the nude locus gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Microanatomical localization of PD-1 in human tonsils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Specific and nonspecific immunity in the prevention of spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-003-0430-2

CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells

21 January 2018

1 reference

12 December 2020

B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum

1 reference

12 December 2020

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

1 reference

12 December 2020

T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance.

1 reference

12 December 2020

Circulating Melan-A/Mart-1 specific cytolytic T lymphocyte precursors in HLA-A2+ melanoma patients have a memory phenotype.

1 reference

12 December 2020

Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial

1 reference

12 December 2020

Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.

1 reference

12 December 2020

How much longer will tumour cells fool the immune system?

1 reference

12 December 2020

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

12 December 2020

Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells

1 reference

12 December 2020

B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function

1 reference

12 December 2020

Vaccination against human cancers (review).

1 reference

12 December 2020

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

1 reference

12 December 2020

Eradication of established tumors by CD8+ T cell adoptive immunotherapy

1 reference

12 December 2020

10.1007/S00109-003-0430-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12721664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference